Last 153.80 INR
Change Today -5.50 / -3.45%
Volume 39.2K
INDR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

indoco remedies ltd (INDR) Snapshot

Open
158.00
Previous Close
159.30
Day High
162.00
Day Low
151.55
52 Week High
06/25/14 - 178.00
52 Week Low
07/31/13 - 55.05
Market Cap
14.2B
Average Volume 10 Days
77.2K
EPS TTM
6.29
Shares Outstanding
92.2M
EX-Date
07/21/14
P/E TM
24.5x
Dividend
1.40
Dividend Yield
0.72%
Current Stock Chart for INDOCO REMEDIES LTD (INDR)

Related News

No related news articles were found.

indoco remedies ltd (INDR) Related Businessweek News

No Related Businessweek News Found

indoco remedies ltd (INDR) Details

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India and internationally. It provides anti-cold, anti-spasmodic, anti-infective, anti-inflammatory, stomatological, anti-fungal, cough and cold preparation, cardiovascular, multivitamin products, etc., as well as anti-bacterial, analgesic, anti-asthamic, anti-spasmodic products, etc. The company also provides anti-hypersensitive toothpaste, anti-septic gel, oral NSAID, antibacterial mouthwash and gel products, etc.; antibiotics and antiemetic products; ophthalmic and ENT products; and lipid lowering agents, antiulcerants, antispasmodics, nutrition and metabolism, diabetic neuropathic pain, steroid, anti-infective, and muscle relaxant products. In addition, it offers APIs in various therapeutic areas, such as antiurolithic, antidiabetic, antipsychotic, antiglaucoma, antihistaminic, antiinflammatory, antispasmodic, antilipemic, antiparkinsonian, and anticonvulsant. Further, the company provides contract research services comprising custom synthesis of molecules and intermediates; process chemistry research and development; non–infringing process designing and scale up; and analytical method development/validation, impurity profiling, and polymorphic studies, as well as contract manufacturing services. It serves general practitioners, consultant physicians, pediatricians, ENTs, cardiologists, diabetologists, endocrinologists, nephrologists, gynecologists, dentists, ophthalmologists, and orthopaedicians. The company, formerly known as Indo Continental Trading Company, was founded in 1945 and is based in Mumbai, India.

4,300 Employees
Last Reported Date: 07/4/13
Founded in 1945

indoco remedies ltd (INDR) Top Compensated Officers

Managing Director, Chief Executive Officer, D...
Total Annual Compensation: 7.6M
Joint Managing Director, Executive Director, ...
Total Annual Compensation: 6.6M
Executive Chairman
Total Annual Compensation: 10.8M
Compensation as of Fiscal Year 2014.

indoco remedies ltd (INDR) Key Developments

Indoco Remedies Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2014

Indoco Remedies Limited reported unaudited standalone earnings results for the fourth quarter and audited standalone and consolidated earnings results for the year ended March 31, 2014. For the quarter on standalone basis, net sales/income from operation was INR 1,858.6 million against INR 1,604.8 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 250.1 million against INR 188.8 million a year ago. Profit form ordinary activities before tax was INR 225.8 million against INR 142.6 million a year ago. Net profit for the period was INR 185.5 million or INR 2.01 per basic and diluted share against INR 128.5 million or INR 1.39 per basic and diluted share a year ago. For the year on standalone basis, net sales/income from operation was INR 7,173.7 million against INR 6,264.3 million a year ago. Profit from operation before other income, finance cost and exceptional items was INR 891.6 million against INR 687.4 million a year ago. Profit form ordinary activities before tax was INR 721.1 million against INR 483.7 million a year ago. Net profit was INR 579.0 million or INR 6.28 per basic and diluted share against INR 426.6 million or INR 4.63 per basic and diluted share a year ago. For the year on consolidated basis, net sales/income from operation was INR 7,222.7 million against INR 6,268.3 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 894.8 million against INR 689.3 million a year ago. Profit form ordinary activities before tax was INR 485.5 million against INR 485.5 million a year ago. Net profit was INR 580.3 million or INR 6.29 per basic and diluted share against INR 427.6 million or INR 4.64 per basic and diluted share a year ago.

Indoco Remedies Limited Recommends Dividend for the Year 2013-14, Payable on or After August 5, 2014

Indoco Remedies Ltd. announced that the board of directors of the company at its meeting held on May 28, 2014, have recommended a dividend of 70% i.e. INR 1.40 per equity share of face value of INR 2 each for the year 2013-14 subject to the approval of shareholders in the ensuing Annual General Meeting. Payable on or after August 5, 2014 to those shareholders whose names appear on the register of members as on the record date.

Indoco Remedies Limited Appoints Anand Nadkarni as Additional Non Executive Director

Indoco Remedies Ltd. announced that the board of directors of the company at its meeting held on May 28, 2014, has approved that the appointment of Dr. Anand Nadkarni as Additional Non Executive Director of the company liable to retire by rotation with effect from May 28, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INDR:IN 153.80 INR -5.50

INDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajanta Pharma Ltd 1,433 INR -12.45
Unichem Laboratories Ltd 194.60 INR -7.90
View Industry Companies
 

Industry Analysis

INDR

Industry Average

Valuation INDR Industry Range
Price/Earnings 22.0x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 14.3x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOCO REMEDIES LTD, please visit www.indoco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.